http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 성낙송(Nak Song Sung) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
유방암으로 항암 치료받는 환자에서 발생하는 과도한 골수 억제의 예측인자
이정석(Jung Suk Lee),이혜윤(Hye Yoon Lee),성낙송(Nak Song Sung),전기원(Ki Won Cheon),문주익(Ju Ik Moon),이상억(Sang Eok Lee),최인석(In Seok Choi),최원준(Won Jun Choi),윤대성(Dae Sung Yoon) 대한종양외과학회 2016 Korean Journal of Clinical Oncology Vol.12 No.1
Purpose: Myelosuppression, particularly neutropenia, is one of the most frequent and serious toxicity seen in patients with breast cancer undergoing systemic chemotherapy. However, the predictive factors for development of severe neutropenia in chemotherapy remain unknown. We therefore evaluated predictive factors for excessive myelosuppression. Methods: We retrospectively analyzed 341 patients with breast cancer treated with chemotherapy from 2000 to 2012. Clinicopathological characteristics, number of using of granulocyte colony-stimulating factor (G-CSF), and pretreatment hematologic values were extracted from the electronic medical record system. Patients were sorted 2 groups by number of using G-CSF in each chemotherapeutic regimens; group 1 is more G-CSF (within high 20 percentile) and 2 less G-CSF using group (within lower 20 percentile). Results: Number of using G-CSF was ranged 0–83 (mean 10.76). One hundred one patients were in group 1 and 65 patients were in group 2. Mean of number of G-CSF using was 0.21 in group 1 and 28.02 in group 2. Pretreatment white blood cell, hemoglobin and platelet count were lower in group 2 than in group 1 (6.88×103/μL vs. 5.97×103/μL, 12.63 g/dL vs. 11.90 g/dL, and 275.95×104 μL vs. 227.37×104 μL). There were no statistically differences in other clinicopathologic characteristics such as age, body mass index or comorbidities, hormonal receptor, stage, and other pretreatment hematologic values. Conclusion: Pretreatment white blood cell count, hemoglobin and platelet count can be used to identify patients at increased risk of significant myelosuppression undergoing chemotherapy with breast cancer. This information can be used to target high-risk patients for prophylactic treatment.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
